Autolus Therapeutics plc (AUTL)Healthcare | Biotechnology | London, United Kingdom | NasdaqGS
1.57 USD
-0.01
(-0.633%) ⇩
(April 21, 2026, 10:50 a.m.
EDT)
Short-term: ★★★★☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:34 p.m. EDT
Autolus is positioned for a catalyst-driven run-up despite deteriorating short-term earnings. The options market is pricing in a move to $2.00+ within weeks, while the fundamental data supports a 'Strong Buy' long-term due to massive cash reserves (approx $217M) against a negligible market cap, yet the price action remains suppressed by recent revenue miss negativity. This creates a high-risk/high-reward asymmetric setup where the fundamental valuation (P/B 0.27) clashes with market sentiment, requiring a strong Q2 readout on autoimmune data to unlock value. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.068911 |
| AutoARIMA | 0.072424 |
| AutoETS | 0.072424 |
| MSTL | 0.074295 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.333 |
| Excess Kurtosis | -0.22 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.028 |
| Market Cap | 417,844,960 |
| Forward P/E | -2.21 |
| Website | https://www.autolus.com |
As of April 18, 2026, 10:34 p.m. EDT: Options flow shows distinct bullish skew for the next month. April 17 OTM calls (Strike 2.0) have significantly higher OI and volume than puts at the same strike, with a dist_pct of +25.0%. Volatility is muted for calls (3-8%) but elevated for near-term puts (16.69%), suggesting tight bid-ask spreads or dealer inventory management rather than panic selling. Long-term options show massive volume in ITM/ATM calls over OTM for June expiration (416 vs 20 external vol), indicating speculation on a larger multi-month move to the upside rather than downside protection. The dominance of ATM options (dist_pct -6.3%) suggests hedging activity or liquidity provision, while the specific flow at 2.0 strikes for expiration levels points to price targets above current ~1.60.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.012499988 |
| Address1 | The Mediaworks |
| Address2 | 191 Wood Lane White City |
| All Time High | 53.24 |
| All Time Low | 1.105 |
| Ask | 1.97 |
| Ask Size | 2 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 1,455,430 |
| Average Daily Volume3 Month | 1,639,724 |
| Average Volume | 1,639,724 |
| Average Volume10Days | 1,455,430 |
| Bid | 1.18 |
| Bid Size | 4 |
| Book Value | 5.91 |
| City | London |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United Kingdom |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.57 |
| Current Ratio | 11.054 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.58 |
| Day Low | 1.52 |
| Display Name | Autolus Therapeutics |
| Earnings Call Timestamp End | 1,774,614,600 |
| Earnings Call Timestamp Start | 1,774,614,600 |
| Earnings Timestamp | 1,774,614,600 |
| Earnings Timestamp End | 1,778,157,000 |
| Earnings Timestamp Start | 1,778,157,000 |
| Ebitda | -68,942,608 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 2.252 |
| Enterprise To Revenue | -143.951 |
| Enterprise Value | -155,250,720 |
| Eps Current Year | -0.93375 |
| Eps Forward | -0.71179 |
| Eps Trailing Twelve Months | -1.08 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.4995 |
| Fifty Day Average Change | 0.070500016 |
| Fifty Day Average Change Percent | 0.047015682 |
| Fifty Two Week Change Percent | -1.2499988 |
| Fifty Two Week High | 2.7 |
| Fifty Two Week High Change | -1.13 |
| Fifty Two Week High Change Percent | -0.4185185 |
| Fifty Two Week Low | 1.15 |
| Fifty Two Week Low Change | 0.42000008 |
| Fifty Two Week Low Change Percent | 0.36521748 |
| Fifty Two Week Range | 1.15 - 2.7 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,529,674,200,000 |
| Float Shares | 33,904,120 |
| Forward Eps | -0.71179 |
| Forward P E | -2.2057068 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 752 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -26,476,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.18083 |
| Held Percent Institutions | 0.77596 |
| Implied Shares Outstanding | 266,143,287 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom. |
| Long Name | Autolus Therapeutics plc |
| Market | us_market |
| Market Cap | 417,844,960 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_562879769 |
| Most Recent Quarter | 1,546,214,400 |
| Net Income To Common | -53,279,500 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 423,167,824 |
| Number Of Analyst Opinions | 10 |
| Open | 1.58 |
| Operating Margins | -65.70746 |
| Payout Ratio | 0.0 |
| Phone | 44 20 3829 6230 |
| Previous Close | 1.58 |
| Price Eps Current Year | -1.6813923 |
| Price Hint | 4 |
| Price To Book | 0.26565146 |
| Price To Sales Trailing12 Months | 387.43158 |
| Profit Margins | 0.0 |
| Quick Ratio | 10.317 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.09091 |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.6329108 |
| Regular Market Day High | 1.58 |
| Regular Market Day Low | 1.52 |
| Regular Market Day Range | 1.52 - 1.58 |
| Regular Market Open | 1.58 |
| Regular Market Previous Close | 1.58 |
| Regular Market Price | 1.57 |
| Regular Market Time | 1,776,783,011 |
| Regular Market Volume | 392,537 |
| Return On Assets | -0.22275 |
| Return On Equity | -0.29621 |
| Revenue Per Share | 0.028 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 266,143,286 |
| Shares Percent Shares Out | 0.0548 |
| Shares Short | 14,582,459 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 14,966,126 |
| Short Name | Autolus Therapeutics plc |
| Short Percent Of Float | 0.0845 |
| Short Ratio | 8.04 |
| Source Interval | 15 |
| Symbol | AUTL |
| Target High Price | 13.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 8.81 |
| Target Median Price | 9.0 |
| Total Cash | 217,450,000 |
| Total Cash Per Share | 5.524 |
| Total Debt | 0 |
| Total Revenue | 1,078,500 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.652975 |
| Two Hundred Day Average Change | -0.08297491 |
| Two Hundred Day Average Change Percent | -0.05019732 |
| Type Disp | Equity |
| Volume | 392,537 |
| Website | https://www.autolus.com |
| Zip | W12 7FP |